Department of Orthopedic Surgery, Center for Hip Preservation, Orthopaedic and Rheumatologic Institute, Cleveland Clinic Foundation, 9500 Euclid Ave, Cleveland, OH, 44195, USA.
Department of Orthopedic Surgery, University Hospitals, Cleveland, OH, 44195, USA.
Eur J Orthop Surg Traumatol. 2024 Apr;34(3):1269-1277. doi: 10.1007/s00590-024-03833-w. Epub 2024 Feb 20.
The photodynamic bone stabilization system (PBSS) was was developed in 2010, and in 2018 gained FDA approval in the United States. Given its relative novelty, our analysis sought to analyze the available literature exploring the indications, outcomes, and complications of the PBSS.
We performed a systematic review (PROSPERO registration of study protocol: CRD42022363065, October 8th, 2022). PubMed, EBSCOHost, and Google Scholar electronic databases were queried to identify articles evaluating PBSS in the treatment of pathologic or traumatic fractures between January 1 2010 and 15 October 2022. The quality of the included studies was assessed using the Methodological Index for Nonrandomized Studies tool.
Our initial search yielded 326 publications, which were then screened for appropriate studies that aligned with the purpose of our review. A total of thirteen studies, comprising seven case series, four case reports, and two cohort studies. The total sample size of the included studies consisted of 345 patients, with 242 females (70%) and 103 males (30%). The implants were most commonly utilized in the humerus (41%), radius (12%), and metacarpal (12%). The most common complications were related to broken implants (5%) and dislocation (1%). Most studies reported complete fracture healing and return of full strength and range of motion.
Despite being a relatively novel technology, PBSS appears to be a viable option for fracture stabilization. Most studies included in our analysis reported complete fracture healing and return of function with minimal complications.
光动力骨稳定系统（PBSS）于 2010 年开发，并于 2018 年获得美国 FDA 的批准。鉴于其相对新颖性，我们的分析旨在分析探索 PBSS 的适应证、结果和并发症的现有文献。
我们进行了系统评价（研究方案的 PROSPERO 注册：CRD42022363065，2022 年 10 月 8 日）。通过 PubMed、EBSCOHost 和 Google Scholar 电子数据库查询评估 PBSS 在治疗病理性或创伤性骨折中的应用的文章，检索时间为 2010 年 1 月 1 日至 2022 年 10 月 15 日。使用非随机研究方法学指数工具评估纳入研究的质量。
我们最初的搜索产生了 326 篇出版物，然后对符合我们审查目的的适当研究进行筛选。共有 13 项研究，包括 7 项病例系列研究、4 项病例报告和 2 项队列研究。纳入研究的总样本量由 345 名患者组成，其中女性 242 名（70%），男性 103 名（30%）。植入物最常用于肱骨（41%）、桡骨（12%）和掌骨（12%）。最常见的并发症与植入物断裂（5%）和脱位（1%）有关。大多数研究报告了完全骨折愈合和完全恢复力量和运动范围。
尽管 PBSS 是一种相对较新的技术，但它似乎是一种可行的骨折稳定选择。我们分析中纳入的大多数研究报告了完全骨折愈合和功能恢复，并发症最小。
